Shelter Pharma Ltd (SHELTER) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Shelter Pharma Ltd on NSE and BSE, with an AI summary of each filing.
Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) ....
Intimation · 07 Nov 2026, 5:30 am
Shelter Pharma Board Meeting on 7th Nov'26 to Consider Half-Yearly Results Shelter Pharma Limited has scheduled a meeting of its Board of Directors on Saturday, 7th Nov'26, to consider, approve, and take on record the un-audited financial results along with the Limited Review Report for the half-year ended 30th Sep'26. Consequently, the company's trading window for dealing in its securities will remain closed until 48 hours following the declaration and publication of the financial results, reopening on Mon, 9th Nov'26.
Attached here with order updates recieved on 28.10.2026
Others (Uncategorized) · 30 Oct 2026, 1:15 am
Shelter Pharma Secures Export Orders Worth Rs 3.47 Crore Shelter Pharma Limited has secured international export orders aggregating USD 364,335 (~Rs 3.47 crore). The awards include a USD 330,975 order from Taha Drugs & Chemicals Co. Ltd. for nutraceutical products (Joemega Capsules, Foliman Tablets, and All Vitamin Tablets), alongside animal feed supplement orders from First Vet Veterinary Medicines Trading L.L.C (USD 23,300) and Genet International (USD 10,060). All transactions fall under the normal course of business with non-related international entities, to be executed per mutually agreed schedules.
Conversion of Warrants into Equity Shares
Others (Uncategorized) · 16 Oct 2026, 8:45 pm
Shelter Pharma Allots 4.65 Lakh Equity Shares on Warrant Conversion Shelter Pharma Limited approved the allotment of 4,65,000 equity shares of face value Rs. 10 each following the conversion of preferential warrants by promoter Mustaqim Nisarahmed Sabugar on 16th Oct'26. The allotment was executed upon receiving the remaining 75% balance of Rs. 31.6875 per warrant, totaling Rs. 1.47 cr, against the issue price of Rs. 42.25 per share. Consequently, the company's paid-up equity capital increased from Rs. 16.84 cr (1,68,36,792 shares) to Rs. 17.30 cr (1,73,01,792 shares).
Outcome of the Board Meeting held on Friday, October 16, 2026 for conversion of warrants into Equity Shares
Others (Uncategorized) · 16 Oct 2026, 8:41 pm
Shelter Pharma Allots 465,000 Equity Shares on Warrant Conversion Shelter Pharma Limited’s Board approved the conversion of 465,000 convertible warrants into 465,000 fully paid equity shares of ₹10 face value to promoter Mustaqim Nisarahmed Sabugar on 16th Oct'26. The allotment followed receipt of the remaining 75% exercise price of ₹31.6875 per warrant, totaling ₹1.47 cr (issue price ₹42.25 per share). Consequently, paid-up equity share capital increased from ₹16.84 cr (16,836,792 shares) to ₹17.30 cr (17,301,792 shares). The allotted shares rank pari-passu with existing equity shares.
Attached herewith Intimation for Regularization of Ms. Vinita Gadhavi as Non Executive Independent Director of the Company.
Change in Management · 30 Sept 2026, 12:10 am
Shelter Pharma Shareholders Approve Vinita Gadhavi as Non-Executive Independent Director Shelter Pharma Limited announced that shareholders approved the regularization and appointment of Ms. Vinita Shivraj Gadhavi as Non-Executive Independent Director at its AGM on 29th Sep'26. The appointment is for a five-year term effective 31st Jul'26 to 30th Jul'31, without liability to retire by rotation. Gadhavi holds a Ph.D. and over 12 years of experience across pharmaceuticals, quality assurance, regulatory compliance, and strategic development. She has no inter-se relationships with existing directors and is not debarred by SEBI.
Attached herewith Voting Results along with Scrutinizer Report of Shelter Pharma Limited
Annual General Meeting · 30 Sept 2026, 12:05 am
Shelter Pharma Limited Shareholders Approve All Seven Resolutions at 19th AGM Shelter Pharma Limited declared the voting results for its 19th AGM held on 29th Sep'26. Shareholders approved all seven resolutions with 100% favorable votes cast across 1.05 cr polled shares (62.35% overall turnout). Key approvals include the FY26 audited standalone financial statements, re-appointment of non-executive director Mrs. Parvezbanu Mohamed Rafiq Idariya, ratification and approval of material related-party transactions for FY27 with Gandhi Brothers, Shelter Pharmacy, and Al Nasheet Global Business, and the regularization of Ms. Vinita Shivraj Gadhavi as Non-Executive Independent Director.
Attached herewith Proceedings of 19th AGM held on Tuesday, 29th September, 2026 at 10:00 A.M.
Annual General Meeting · 29 Sept 2026, 9:18 pm
Positive Doctor''s Review and Feedback on Company Products
Others (Uncategorized) · 23 Sept 2026, 5:04 pm
Shelter Pharma Receives Positive Doctor Endorsement for Key Healthcare Products Shelter Pharma reported receiving positive feedback on social media from Dr. C.M. Patel regarding key offerings in its Human Healthcare segment, including Lemonade Barley Water, Alkaliser syrup, and Joemega capsules. The review highlighted product efficacy, unique formulations, 100% natural composition, and benefits for children's growth and development. Disclosed voluntarily on 23rd Sep'26, the company expects the endorsement to strengthen brand credibility and professional acceptance within the medical community, though it anticipates no immediate material impact on financials.
Intimation Under Regulation 30 of SEBI (LODR) Regulations, 2015, Receipt of Significant International Purchase Order.
Others (Uncategorized) · 22 Sept 2026, 5:53 pm
Shelter Pharma Secures Export Order Worth USD 10,150 from Berlin International Shelter Pharma Limited has received an international purchase order from Berlin International Company in the normal course of business. The export contract entails supplying 3,500 units of nutraceutical product "D3 CURE 50 ML" at USD 2.90 per unit, totaling USD 10,150 (approx. Rs. 9.72 lakh). The order execution will adhere to mutually agreed purchase timelines. The transaction does not involve related-party interests and aligns with the company’s strategic objective to expand its international footprint and revenue base in the global nutraceutical and healthcare market.
Attached herewith Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 18 Sept 2026, 4:59 pm
Shelter Pharma Participates in Vishwa Ayurveda Parishad Exhibition in Jaipur Shelter Pharma Limited participated in the Vishwa Ayurveda Parishad Exhibition held on 17th-18th Sep'26 in Jaipur, organized alongside the National Institute of Ayurved. The company secured a dedicated stall to showcase its pharmaceutical and healthcare product portfolio to attending physicians, scholars, researchers, and industry delegates. Management expects this participation to enhance brand visibility, expand business associations within the professional Ayurvedic community, and support its long-term business development strategy.
Attached herewith Newspaper Publication for 19th AGM of the Company to be held on Tuesday, 29th September, 2026
Annual General Meeting · 07 Sept 2026, 4:36 pm
Attached herewith Notice of 19th AGM of the Company to be held on Tuesday, 29th September, 2026 at 10:00 A.M.at registered office of the Company
Annual General Meeting · 04 Sept 2026, 11:48 pm
Attached herewith 19th Annual report of Shelter Pharma Limited
Others (Uncategorized) · 04 Sept 2026, 11:45 pm
Intimation of the Cut-off date of the AGM of the Company "SHELTER PHARMA LIMITED" to be held on Tuesday 29th September, 2026.
Annual General Meeting · 01 Sept 2026, 8:12 pm
Intimation for Regularization of Additional Director, Ms. Vinita Shivraj Gadhavi (DIN: 09102407) as Non-Executive Independent Director of the Company.
Change in Management · 01 Sept 2026, 8:07 pm
Shelter Pharma Appoints Vinita Gadhavi as Non-Executive Independent Director On 01st Sep'26, Shelter Pharma's board approved the regularization of Ms. Vinita Shivraj Gadhavi as a Non-Executive Independent Director. Her five-year term is effective from 31st Jul'26 to 30th Jul'31, subject to shareholder approval. The appointment changes her designation from Additional Director. Ms. Gadhavi has over 12 years of experience in pharmaceuticals, holds a Ph.D., and has expertise in quality assurance, strategic business development, and R&D. She is not related to any other directors and is not debarred by any SEBI order.
The Board of Directors of the Company at their meeting held on Tuesday, 01ST September, 2026 at 01:45 PM At the corporate office of the company at 5th Floor, 501 Sakar 4, Opp. MJ Library ....
Others (Uncategorized) · 01 Sept 2026, 8:03 pm
Shelter Pharma Board Approves Director Changes and AGM Details Shelter Pharma's board, in its meeting on 01st Sep'26, approved key resolutions. Ms. Vinita Shivraj Gadhavi was regularized as a Non-Executive Independent Director for a five-year term from 31st Jul'26 to 30th Jul'31. The board also approved the re-appointment of Mrs. Parvezbanu Mohamed Rafiq Idariya. The 19th AGM is scheduled for 29th Sep'26, with 22nd Sep'26 set as the cut-off date for voter eligibility. Remote e-voting will be available from 26th Sep'26 to 28th Sep'26. Approvals for related party transactions were also passed.
Intimation Under Regulation 30 of SEBI LODR (Regulation) - 2015 Completion and Commencement of Dispatch of Export Order
Others (Uncategorized) · 25 Aug 2026, 6:04 pm
Shelter Pharma Completes and Dispatches Sudan Export Order Shelter Pharma has completed manufacturing and dispatched an export order to Sudan for Taha Drugs & Chemicals Co. Ltd. The order, valued at USD 139,200, was for nutraceutical tablets (Foliman) and capsules (Joemega). The company highlights strong demand from Sudan through repeat orders and notes a total market opportunity of approximately ₹50 crore in the region. This successful dispatch reinforces its global expansion plans and its growing presence in the Sudanese nutraceutical market, which is now providing exclusive orders.
Intimation Under Regulation 30 of SEBI LODR (Regulation) - 2015 Completion and Commencement of Dispatch of Export Order
Others (Uncategorized) · 24 Aug 2026, 5:21 pm
Shelter Pharma Completes $144,000 Export Order to Sudan Shelter Pharma has successfully completed and dispatched an export order worth USD 144,000 to Sudan, as of 24 Aug '26. The order, for Nutraceutical Tablets from customer Taha Drugs & Chemicals Co. Ltd, has been fully manufactured, dispatched, and settled. This milestone reflects the company's growing international presence in the pharmaceutical and nutraceutical sectors. The initial purchase order intimation was made on 29 Apr '26.
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015- New Product Launch
Others (Uncategorized) · 21 Aug 2026, 5:55 pm
Shelter Pharma Launches New Ayurvedic Cough Spray Shelter Pharma announced the launch of a new Ayurvedic product, SHELTIDIN DS, a herbal cough spray. The product was launched on 20th Aug'26 and is available on e-commerce platforms. SHELTIDIN DS is designed to provide relief from dry cough, sore throat, and irritation. Developed in-house, the product currently targets the domestic market, with potential for future international expansion. This launch aligns with the company's focus on innovation and its long-term growth strategy within the healthcare segment.
Intimation under Regulation 30 of SEBI LODR (Regulation)- 2015 Completion and Commencement of Dispatch of Export Order
Others (Uncategorized) · 20 Aug 2026, 6:26 pm
Shelter Pharma Completes and Dispatches Export Order to Bangladesh Shelter Pharma has successfully completed and dispatched an export order for veterinary feed supplements to Genet International in Bangladesh. The order, valued at USD 12,285, was first intimated on 27th Jul'26 and has now been fully manufactured, settled, and shipped as of 20th Aug'26. This marks a positive development in the company's international expansion, fulfilling its commitment to timely delivery. The company views this as a significant milestone, reflecting its growing global presence in the pharmaceutical and nutraceutical sectors.
Intimation Under Regulation 30 of SEBI (Regulation) 2015- Completion and Commencement of Dispatch of Export Order.
Others (Uncategorized) · 10 Aug 2026, 4:29 pm
Shelter Pharma Completes and Dispatches USD 103,538 Export Order to Sudan Shelter Pharma Limited announced on 10 Aug'26 the successful completion and dispatch of an export order for All Vitamins Tablets to Sudan. The order, valued at USD 103,538, was placed by Taha Drugs & Chemicals Co. Ltd. The company confirmed that the full amount has been settled and the entire order has been dispatched, marking a significant milestone in its global expansion efforts. This fulfillment underscores the company's manufacturing and delivery capabilities within stipulated timelines.
Attached herewith Intimation for Appointment of Independent Director of the Company i.e Ms. Vinita Gadhvi on Board of Shelter Pharma Limited
Change in Management · 31 Jul 2026, 5:02 pm
Shelter Pharma Appoints Dr. Vinita Gadhvi as Independent Director Shelter Pharma Limited has appointed Dr. Vinita Shivraj Gadhvi as an Additional Non-Executive Independent Director, effective 31st Jul'26. Her appointment is for a five-year term, subject to shareholder approval. Dr. Gadhvi brings over 12 years of experience in pharmaceuticals, healthcare innovation, quality systems, and strategic growth. She holds a Ph.D. focused on the Indian Healthcare Startup Ecosystem and has expertise in regulatory compliance, business development, and R&D. She is not related to any existing directors or key personnel.
The Board of Directors of the Company at its meeting held today, i.e. Friday, 31st July, 2026 has discussed, approved, and taken on record the following matters attached herewith
Others (Uncategorized) · 31 Jul 2026, 4:57 pm
Shelter Pharma Appoints Independent Director, Reconstitutes CSR Committee Shelter Pharma's board has appointed Ms. Vinita Shivraj Gadhvi as an Additional Non-Executive Independent Director, effective 31st Jul'26, for a five-year term, pending shareholder approval. Ms. Gadhvi has over 12 years of experience in pharmaceuticals and healthcare innovation. Concurrently, the company reconstituted its Corporate Social Responsibility (CSR) Committee. Mr. Mosinkhan Gafarkhan Pathan will serve as Chairman, with Ms. Gadhvi, Mr. Mustaqim Nisarahmed Sabugar (MD), and Mrs. Parvezbanu Mohamed Rafiq Idariya appointed as members, effective 31st Jul'26.
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015-Receipt of Significant International Purchase Orders.
Others (Uncategorized) · 27 Jul 2026, 5:03 pm
Shelter Pharma Secures USD12,285 International Export Order Shelter Pharma Limited has received an international purchase order from Genet International valued at USD12,285. The order is for the supply of various Veterinary Feed Supplement products, including FEEDMIN BOLUS, REGULIN BOLUS, Lactocal Gel, and BUTA-B BOLUS. This transaction is considered a normal course of business and is expected to enhance the company's export revenue and global presence. The order does not involve any promoter group interest or fall under related party transactions. Execution timelines will follow the purchase order schedule.
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015-Receipt Order from Verka Dairy Ludhiana.
Others (Uncategorized) · 24 Jul 2026, 5:08 pm
Shelter Pharma Wins Purchase Order from Verka Dairy Ludhiana Shelter Pharma has received a purchase order from Verka Dairy Ludhiana, a brand of MILKFED Punjab, for the supply of Veterinary Feed Supplements. The total order value is INR 50,347.50. This domestic order, secured in the normal course of business, includes DIA-VET BLOUS (INR 17,200) and UTRON (INR 30,750). The company expects this order to positively contribute to future revenues and profitability. The transaction does not involve any promoter group interest or related party transactions.